Program Committee
Co-Chairs
-(002).tmb-thumbnail.jpg?sfvrsn=2677422d_1)
Senior Vice President, HEOR, Sema4, Princeton, NJ, USA

Chief Executive, National Institute of Health and Care Excellence (NICE), London, England, UK

Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
Members
Blythe Adamson, PhD, MPH
Senior Quantitative Scientist, Flatiron Health, New York, NY, USA
Tamás Ágh, MD, PhD, MSc
Principal Researcher, Syreon Research Institute, Pecs, Hungary
Suliman Alghnam, PhD
Head of Population Health, King Abdulah International Medical Research Center, Riyadh, Saudi Arabia
Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, London, England, UK
Jon Campbell, PhD, MS
Senior Vice President for Health Economics, ICER, Boston, MA, USA
Bruce Crawford, MA, MPH
Vice President, Real World & Late Phase, APAC, Syneos Health, Tokyo, Japan
Gregory Daniel, MPH, RPh, PhD
Global Head of Public Policy, Global Corporate Affairs, Eli Lilly and Company, Washington, DC, USA
Ratna Devi, MBA
CEO and Co-founder, DakshamA Health and Education, Board Member, International Alliance of Patients’ Organizations, New Delhi, India
Vijay S. Gc, MPH, PhD
Research Fellow, Centre for Health Economics, University of York, York, England, UK
Juan Marcos Gonzalez, PhD
Assistant Professor, Department of Population Health Sciences, Duke University, Durham, NC, USA
Michael Grabner, PhD
Principal Scientist, HealthCore, Inc., Wilmington, DE, USA
Lisa Hess, PhD
Senior Research Advisor, Eli Lilly and Company, Indianapolis, IN, USA
Nicholas Latimer, BSc, MSc, PhD
Reader in Health Economics, ScHARR - University of Sheffield, Sheffield, England, UK
Vittorio Maio, PharmD, MS, MSPH
Research Professor, Thomas Jefferson University, Philadelphia, PA, USA
Stephanie Manson, PhD
Senior Director, HEOR Excellence, Novartis, East Hanover, NJ, USA
Robert Brett McQueen, PhD, MS
Assistant Professor, Center for Pharmaceutical Outcomes Research (CePOR), Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Homero Monsanto, PhD, MS
Health Economics and Outcomes Researcher, Guaynabo, Puerto Rico
Michelle Mujoomdar, PhD
Director, Strategic Policy Branch, Health Canada, Ottawa, ON, Canada
Tarlan Namvar, PharmD, MS
Health Economics and Outcomes Research Fellow, Adjunct Faculty, Piscataway, NJ, USA
Soumana Chamoun Nasser, BS Pharm, PharmD, MS
Clinical Associate Professor, Chair, Department of Pharmacy Practice, Department of Pharmacy Practice, Lebanese American University, Byblos, Lebanon
Maciej Niewada, MD
President, ISPOR Poland Regional Chapter Office; Professor, Department of Clinical & Experimental Pharmacology of Medical University of Warsaw; HEALTHQUEST Company, Warsaw, Poland
William Padula, PhD
Assistant Professor of Pharmaceutical and Health Economics, Schaeffer Center for Health Policy and Economics, USC School of Pharmacy, Los Angeles, CA, USA
Bray Patrick-Lake, MFS
Director of Strategic Partnerships, Evidation Health, San Mateo, CA, USA
Casey Quinn, MPhil, PhD
Senior Advisor for Patient-Centered Economic Outcomes, Patient-Centered Outcomes Research Institute (PCORI), Washington, DC, USA
Alfonso J. Rodríguez-Morales, MSc, ScD, MD
Professor of Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia
Claire Rothery, MSc, MSci, PhD, MPhil
Senior Research Fellow, Centre for Health Economics, University of York, York, England, UK
Asrul Akmal Shafie, PhD
Associate Professor, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
Julia Slejko, PhD
Associate Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA
Mehtap Tatar, BSc, MSc, PhD
Director, Polar Health Economics and Policy Consultancy, Ankara, Turkey
Xiao Xu, PhD, MA
Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine; Faculty member of the Yale Center for Outcomes Research & Evaluation (CORE) and Yale Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER), New Haven, CT, USA